✦ LIBER ✦

Development of novel treatments for hepatitis C

✍ Scribed by Daniel P Webster; Paul Klenerman; Jane Collier; Katie JM Jeffery

Book ID: 117791156
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 133 KB
Volume: 9
Category: Article
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(09)70020-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of novel agents for the trea

Development of novel agents for the treatment of hepatitis C virus

✍ Tracy Swan; Raymond T. Chung 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 1 views

Development of novel agents for the trea

Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations

✍ Kenneth E. Sherman; Russell Fleischer; Katherine Laessig; Jeffrey Murray; Willia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

The Development of a Modified Human IFN-

The Development of a Modified Human IFN-α2b Linked to the Fc Portion of Human IgG1 as a Novel Potential Therapeutic for the Treatment of Hepatitis C Virus Infection

✍ Jones, Tim D.; Hanlon, Marian; Smith, Beverley J.; Heise, Charles T.; Nayee, Pra 📂 Article 📅 2004 🏛 Mary Ann Liebert 🌐 English ⚖ 306 KB

First-line treatments for hepatitis C

✍ A. Messori; F. Del Santo; D. Maratea 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Development of novel antiviral therapies

Development of novel antiviral therapies for hepatitis C virus

✍ Kai Lin 📂 Article 📅 2010 🏛 SP Wuhan Institute of Virology, CAS 🌐 English ⚖ 526 KB

Cost-effectiveness of treatments for chr

Cost-effectiveness of treatments for chronic hepatitis C

✍ John B Wong 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 223 KB